myotubularin gene-encoding AAV 8 vector based therapy (Genethon/Wake Forest University/University of Washington/Harvard Medical School/INSERM)
N/A
Report date: 2025/01/26 18:25:45
Base Information
Drug Namemyotubularin gene-encoding AAV 8 vector based therapy (Genethon/Wake Forest University/University of Washington/Harvard Medical School/INSERM)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGenethon
China Registration ClassN/A
Develop Information
Active CompaniesInstitut National De La Sante Et De La Recherche MedicaleWake Forest UniversityKinea Bio Inc +[7]
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A